跳至主要内容
临床试验/NL-OMON54058
NL-OMON54058招募中4 期

Monitoring immunogenicity of SARS-Cov-2 vaccination in Dutch middle-aged and older individuals (participating in the Doetinchem Cohort Study) - VIDO

Ministerie van Volksgezondheid, Welzijn en Sport (VWS)0 个研究点目标入组 1,700 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
1,700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Having participated in round 6 of the Doetinchem Cohort study or living in a
  • nursing home
  • Willing to receive the SARS-CoV-2 vaccine or received the vaccination not
  • longer than 1 month in advance for the DC participants or not longer than 7
  • months ago for nursing home residents.
  • Willing to sign the Informed Consent.

排除标准

  • * DCS Participant already received his second SARS-CoV-2 vaccination more than
  • 1 month before signing the ICF, so sampling at T2 and further is not possible.
  • * participants living in a nursing home already received both primary
  • SARS-CoV-2 vaccinations
  • more than 7 months before signing ICF.
  • * Incapacitated participants

研究者

发起方
Ministerie van Volksgezondheid, Welzijn en Sport (VWS)

相似试验